Arcutis Biotherapeutics (ARQT) EBT Margin (2022 - 2026)
Arcutis Biotherapeutics (ARQT) reported EBT Margin of 11.66% for Q2 2026, up 30.73 percentage points from -19.07% a year earlier and up 22.29 percentage points from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) EBT Margin (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Arcutis Biotherapeutics' EBT Margin came in at 6.31%, up 41.36 percentage points year-over-year; for FY2025, it was -3.98%, up 66.94 percentage points from FY2024.
- EBT Margin has increased for three consecutive years, with a three-year change of +8445.78 percentage points (FY2022 to FY2025).
- By year, EBT Margin came in at -70.92% in FY2024 (+363.64 pp), -434.57% in FY2023 (+8015.19 pp) and -8449.76% in FY2022.
- Five-year quarterly EBT Margin spans a low of -14856.41% in Q3 2022 and a high of 13.80% in Q4 2025.
- Year over year, EBT Margin has now increased in each of the last 12 quarters, with an average year-over-year change of +107.76 percentage points over the last eight quarters.
- The year-over-year gain in EBT Margin has ranged between 16.72 percentage points (Q3 2024) and 14746.88 percentage points (Q3 2023) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at -10.63% (Q1 2026), 13.80% (Q4 2025) and 7.55% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Arcutis Biotherapeutics | 3.43 Bn | 2.72 Bn | 118.92 Mn | 11.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.66% |
| Mar 31, 2026 | -10.63% |
| Dec 31, 2025 | 13.80% |
| Sep 30, 2025 | 7.55% |
| Jun 30, 2025 | -19.07% |
| Mar 31, 2025 | -37.63% |
| Dec 31, 2024 | -14.67% |
| Sep 30, 2024 | -92.81% |
| Jun 30, 2024 | -169.59% |
| Mar 31, 2024 | -70.73% |
| Dec 31, 2023 | -489.86% |
| Sep 30, 2023 | -109.53% |
| Jun 30, 2023 | -1,367.84% |
| Mar 31, 2023 | -2,880.26% |
| Dec 31, 2022 | -2,432.25% |
| Sep 30, 2022 | -14,856.41% |
API Access
Arcutis Biotherapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();